PKCα inhibited apoptosis by decreasing the activity of JNK in MCF-7/ADR cells

Experimental and Toxicologic Pathology

Volumn 64, Issue 5, 2012, Pages 459-464

  Wang, Na ^a   Li, Zhihua ^a   Tian, Fen ^a   Feng, Ying ^a   Huang, Jintao ^a   Li, Chaohong ^a   Xie, Fukang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; JNK; MDR; PKC

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; PROTEIN KINASE C ALPHA; STRESS ACTIVATED PROTEIN KINASE; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; FEMALE; FLOW CYTOMETRY; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; PROTEIN KINASE C-ALPHA; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84860467023     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.10.014     Document Type: Article

References (40)

1. Bennet B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazolone inhibitor of c-Jun N-terminal kinase. Proc Natl Acad Sci USA 2001, 98:13681-13686.
2. Brozovic A., Fritz G., Christmann M., Zisowsky J., Jaehde U., Osmak M., et al. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Int J Cancer 2004, 112:974-985.
3. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
4. Chiarini F., Del Sole M., Mongiorgi S., Gaboardi G.C., Cappellini A., Mantovani I., et al. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia 2008, 22:1106-1116.
5. Cho Y., Talmage D.A. Protein kinase Cα expression confers retinoic acid sensitivity on MDA-MB-231 human breast cancer cells. Exp Cell Res 2001, 269:97-108.
6. Desai P.B., Bhardwaj R., Damle B. Effect of tamoxifen on mitoxantrone cytotoxicity in drug-sensitive and multidrug-resistant MCF-7 cells. Cancer Chemother Pharmacol 1995, 36(5):368-372.
7. Dong Y.G., Chen D.D., He J.G., Guan Y. Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells. Acta Pharmacol Sin 2004, 25:47-53.
8. Fine R.L., Patel J., Chabner B.A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci USA 1998, 85:582-586.
9. Frankel L.B., Lykkesfeldt A.E., Hansen J.B., Stenvang J. Protein kinase Cα is a marker for antiestrogen resistance and is involved in the growth of TAM resistant human breast cancer cells. Breast Cancer Res Treat 2007, 104:165-179.
10. Gary L.J., Razvan L. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
11. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007, 7:281-294.
12. Gutcher I., Webb P.R., Anderson N.G. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 2003, 60:1061-1070.
13. Hug H., Sarre T.F. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem J 1993, 291:329-343.
14. Kang C.D., Ahn B.K., Jeong C.S., Kim K.W., Lee H.J., Yoo S.D., et al. Downregulation of JNK/SAPK activity is associated with the crossresistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Exp Cell Res 2000, 256:300-307.
15. Khwaja A., Tatton L. Caspase-mediated proteolysis and activation of protein kinase C delta plays a central role in neutrophil apoptosis. Blood 1999, 94:291-301.
16. Lagadinou E.D., Ziros P.G., Tsopra O.A., Dimas K., Kokkinou D., Thanopoulou E., et al. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia. Leukemia 2008, 22:1899-1908.
17. Lage H. An overview of cancer multidrug resistance: a still unsolved problem. Cell Mol Life Sci 2008, 65(20):3145-3167.
18. Lee J.Y., Hannun Y.A., Obeid L.M. Ceramide inactivates cellular protein kinase C alpha. J Biol Chem 1996, 271:13169-13174.
19. 2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells. Apoptosis 2006, 11:1239-1246.
20. 2-terminal kinase 1. Biochem Biophys Res Commun 2005, 335:1070-1077.
21. Lin X., Yu Y., Zhao H., Zhang Y., Manela J., Tonetti D.A. Overexpression of PKCα is required to impart estradiol inhibition and TAM-resistance in a T47D human breast cancer tumor model. Carcinogenesis 2006, 27:1538-1546.
22. Liu Z.G., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death. Cell 1996, 87:565-576.
23. López-Bergami P., Habelhah H., Bhoumik A., Zhang W., Wang L.H., Ronai Z. RACK1 mediates activation of JNK by protein kinase C. Mol Cell 2005, 19:309-320.
24. Mackay H.J., Twelves C.J. Targeting the protein kinase C family: are we there yet?. Nat Rev Cancer 2007, 7:554-562.
25. Mandlekar S., Kong A.N. Mechanisms of tamoxifen-induced apoptosis. Apoptosis 2001, 6(6):469-477.
26. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö6976. J Biol Chem 1993, 268:9194-9197.
27. Mehta K. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 1994, 58(3):400-406.
28. Miao Z.H., Ding J. Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res 2003, 63:4527-4532.
29. Migliaccio A., Pagano M., Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 1993, 8:2183-2191.
30. Nishina H., Fischer K.D., Radvanyi L., Shahinian A., Hakem R., Rubie E.A., et al. Stress signalling protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 1997, 385:350-353.
31. Orlandi L., Binda M., Folini M., Bearzatto A., Villa R., Daidone M.G., et al. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis. Prostate 2003, 54:133-143.
32. Qatsha K.A., Rudolph C., Marmé D., Schächtele C., May W.S. Gö6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc Natl Acad Sci USA 1993, 90:4674-4678.
33. Ring A., Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 2004, 11:643-658.
34. Ruvolo P.P., Deng X., Carr B.K. A functional role for mitochondrial protein kinase C α in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 1998, 273:25436-25442.
35. Tonetti D.A., Morrow M., Kidwai N., Gupta A., Badve S. Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. Br J Cancer 2003, 88:1400-1402.
36. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000, 288:870-874.
37. Wada T., Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004, 23:2838-2849.
38. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int Rev Cyto 1980, 68:251-306.
39. Yu G., Ahmad S., Aquino A., Fairchild C.R., Trepel J.B., Ohno S., et al. Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 1991, 3:181-189.
40. Zanke B.W., Boudreau K., Rubie E., Winnett E., Tibbles L.A., Zon L., et al. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 1996, 6:606-613.